Health care law company Frier Levitt has analyzed FDA enforcement steps in opposition to “research only” peptide sellers. Their summary: the FDA considers an item’s classification dependant on its intended use, not its disclaimers. When Web-sites incorporate dosage guides, reconstitution Guidelines, or url to discussion boards talking about h